Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) announced its third quarter report for 2024 on October 22. During the reporting period, the revenue was 0.255 billion yuan, an increase of 15.64% year-on-year; the net income attributable to shareholders of the listed company was 3.3142 million yuan, a decrease of 77.35% year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.8144 million yuan, a decrease of 79.13% year-on-year; the basic earnings per share was 0.0109 yuan.
陇神戎发(300534.SZ)：第三季度净利润331.42万元 同比下降77.35%
gansu longshenrongfa pharmaceutical industry (300534.SZ): net income in the third quarter was 3.3142 million yuan, a decrease of 77.35% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated